Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trichlorethanol SCHEMBL325071 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL7261325 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL759616 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL1436780 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL8522341 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL16162174 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL4450822 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL88329 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL762332 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL6898269 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114989190-B | Macrolide compound kongjuemycin, preparation method and application thereof | 中国科学院南海海洋研究所 | 2024-02-09 | — | — | CN | claimed |
| CN-114989190-A | Macrolide compound kongjuemycins and preparation method and application thereof | 中国科学院南海海洋研究所 | 2022-09-02 | — | — | CN | claimed |
| US-20240228505-A1 | BICYCLIC PYRIDINE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2024-07-11 | — | — | US | disclosed |
| WO-2024053648-A1 | LIPID NANOPARTICLES | 国立大学法人九州大学 | 2024-03-14 | — | — | WO | disclosed |
| CN-114989190-B | Macrolide compound kongjuemycin, preparation method and application thereof | 中国科学院南海海洋研究所 | 2024-02-09 | — | — | CN | disclosed |
| WO-2024014536-A1 | REAGENT FOR DETECTING SARS-RELATED CORONAVIRUS | 国立研究開発法人産業技術総合研究所 | 2024-01-18 | — | — | WO | disclosed |
| CN-117177977-A | Bicyclic pyridine derivatives | 住友制药株式会社 | 2023-12-05 | — | — | CN | disclosed |
| CN-114989190-A | Macrolide compound kongjuemycins and preparation method and application thereof | 中国科学院南海海洋研究所 | 2022-09-02 | — | — | CN | disclosed |
| US-20220256902-A1 | NOVEL STEVIOL GLYCOSIDE, METHOD FOR PRODUCING SAME, AND SWEETENER COMPOSITION CONTAINING SAME | SUNTORY HOLDINGS LIMITED (JP) | 2022-08-18 | — | — | US | disclosed |
| EP-4005371-A1 | PLANT BODY CONTAINING NOVEL STEVIOL GLYCOSIDE | Suntory Holdings Limited (JP) | 2022-06-01 | — | — | EP | disclosed |
| EP-4006046-A1 | NOVEL STEVIOL GLYCOSIDE, METHOD FOR PRODUCING SAME, AND SWEETENER COMPOSITION CONTAINING SAME | Suntory Holdings Limited (JP) | 2022-06-01 | — | — | EP | disclosed |
| EP-0157609-A2 | Lipid derivatives their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-10-09 | — | — | EP | disclosed |
| EP-0057441-B1 | MIXED ETHER COMPOSITIONS CONTAINING OLIGOMERS OF POLYFUNCTIONAL PHOSPHINE OXIDES AND METHOD FOR THEIR MANUFACTURE | FMC Corporation (US) | 1985-09-11 | — | — | EP | disclosed |
| EP-0097202-A1 | Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1984-01-04 | — | — | EP | disclosed |
| US-4377653-A | Mixed ether compositions containing oligomers of polyfunctional phosphine oxides: flame retardants for polymers | FMC CORPORATION (US) | 1983-03-22 | — | — | US | disclosed |
| EP-0057441-A2 | Mixed ether compositions containing oligomers of polyfunctional phosphine oxides and method for their manufacture | FMC Corporation (US) | 1982-08-11 | — | — | EP | disclosed |
| EP-0002695-B1 | ORGANOCHEMICAL COMPOUND, PROCESS FOR ITS PREPARATION, ITS USE, COMPOSITIONS CONTAINING IT, AND MICROORGANISMS | BAYER AG (DE) | 1981-11-04 | — | — | EP | disclosed |
| US-4273571-A | STREPTOMYCES CULTURE PRODUCT | BAYER AKTIENGESELLSCHAFT (DE) | 1981-06-16 | — | — | US | disclosed |
| US-4251517-A | FUNGICIDES | CIBA-GEIGY CORPORATION (US) | 1981-02-17 | — | — | US | disclosed |
| EP-0002695-A2 | Organochemical compound, process for its preparation, its use, compositions containing it, and microorganisms | BAYER AG (DE) | 1979-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228505-A1 | BICYCLIC PYRIDINE DERIVATIVE | CBR1, CBR3, CYB5R3 | LMNA 3722/4885TDP1 4135/4885TP53 2383/4885 |
| US-20220256902-A1 | NOVEL STEVIOL GLYCOSIDE, METHOD FOR PRODUCING SAME, AND SWEETENER COMPOSITION CONTAINING SAME | SLC5A1, SLC5A2, UGGT1 | LMNA 4866/4885TDP1 1175/4885TP53 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.